Drug Synthesis Research Group

The research group works in the design, synthesis and biological assessment of pharmacologically active compounds opposite to different pharmacological targets related to anticancer (Glioma inhibitor), antihyperpigmentation (Tyrosinase Inhibitor) and antiosteoporosis (C-Telopeptide inhibitors) materials, addressing pressing global challenges in healthcare, environmental management, and energy.